Category Archives: Covering medical studies

Flesh out your coverage of infectious diseases with historical data

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

Photo: Wellcome Images via Flickr

Photo: Wellcome Images via Flickr

Any time there is an outbreak of an infectious disease, the public wants to know how common it is and its risk of contracting it. When covering breaking cases, journalists should provide context by including information on historical incidence and trends.

Here are some resources for infectious diseases exclusively within the United States. Continue reading

False positives matter: A real-life case study in understanding context

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

Photo: National Institute of Allergy and Infectious Diseases

Photo: National Institute of Allergy and Infectious Diseases

Something happened in our family early in August that set me behind in my work for more than three months. What we experienced holds an important lesson for health journalists.

It is something seemingly small and simple, but with significant potential consequences. However, I need to provide a bit of context in my story to illustrate a phenomenon journalists need to keep in mind when reporting on screening and diagnostic tests. Continue reading

AHCJ objects to FDA’s ‘close-hold embargoes,’ requests explanation

Felice J. Freyer

About Felice J. Freyer

Felice J. Freyer is AHCJ's treasurer and chair of the organization's Right to Know Committee. She is a health care reporter for The Boston Globe.

Image by Logan Campbell via flickr.

Image by Logan Campbell via flickr.

AHCJ is protesting the Food and Drug Administration’s recent restrictive practices in handling news embargoes and has asked the agency for clarification of its policies.

In an Oct. 11 letter to Jason Young, the FDA’s acting assistant commissioner for media affairs, AHCJ President Karl Stark raised strong objections to the practice of providing embargoed information on the condition that reporters refrain from seeking outside comment until the embargo lifts. Continue reading

Breaking up with EurekAlert!: Where to find other studies

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

Photo: Tim Malabuyo via Flickr

Photo: Tim Malabuyo via Flickr

In a previous blog post about EurekAlert!, I described some advantages to using the service less often than many reporters new to the health beat often do. But that post didn’t address how you can start leaving those EurekAlert! email updates unopened in your inbox.

Here are several tips to help you become less dependent on EurekAlert!. Tip: These alternatives can result in adding email alerts to your inbox each day, so it may be worth setting up a dedicated email address for all the lists you’re on. Continue reading

EurekAlert! is back, but do you really need it?

Tara Haelle

About Tara Haelle

Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.

When the EurekAlert! press release service was taken down on Sept. 13 after being hacked, there was a discussion about how much journalists rely on embargoes — and whether those standard practices should continue. A post at Embargo Watch succinctly summarized the pros and cons of abandoning the embargo system, leading to a robust dialogue in the comments section.

With EurekAlert! back up as of Oct. 3, it’s likely back to business as usual for those who relied on the service extensively. Continue reading